NCT04535609 · Interventional trial
An Efficacy and Safety Study of 24 Week Treatment With Mavodelpar (REN001) in Primary Mitochondrial Myopathy Patients
Overall registry status Completed
Phase 2
Conditions Primary Mitochondrial Myopathy
Delaware Valley sites
- The Children's Hospital of Philadelphia · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory